George Scangos

Following an announcement by Biogen Inc (NASDAQ: BIIB) elevating Michel Vounatsos, the company's chief commercial officer and a recent hire from Merck & Co., Inc. (NYSE: MRK), as CEO, Jefferies said the near-term potential for a takeout is reduced. The firm continues to see the reward/...